Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)

The summary for the Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20): -Purpose. This solicitation invites applications for the development of Exploratory Translational Research Centers on the clinical neurobiology of drug abuse and addiction.For purposes of this FOA, an Exploratory Translational Research Center is defined as an entity with a strong primary human neurobiology focus in which preclinical research is included to directly inform or provide a mechanistic foundation for the human neuroscience/neurobiological research. -Mechanism of Support. This FOA will use the NIH P20 award mechanism. The P20 is a planning grant mechanism to promote the development of mature translational research centers by the end of the funding period. The focus of these applications should be on the development of appropriate infrastructure, including personnel and resources, and the generation of sufficient high quality data to provide the basis for a mature P50 translational research center application by the end of the funding period.Features that distinguish a P20 from other center grant mechanisms include: (1) Proposed centers must be comprised of at least three, but no more than five, scientific projects; the primary specific aim must propose to conduct human neurobiological research and at least one of the aims must conduct preclinical (non-human) research. (2) Each research project should have the characteristics of a traditional research project grant, although the projects are expected to be smaller in scale than might be proposed for an individual research application. (3) Because one of the goals of this FOA is to foster the development of new collaborations and research teams, such projects, by design, are considered high risk/exploratory and are encouraged. (4) Preliminary data from nascent or as yet formed research collaborations are not expected, evidence of capacity to contribute to the proposed research collaborations, however, is expected. -Funds Available and Anticipated Number of Awards. NIDA intends to commit $3.0 million dollars in FY2009 to fund 2-3 new grants in response to this FOA.
Federal Grant Title: Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-09-012
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Feb 27, 2009
Original Application Deadline: Feb 27, 2009
Posted Date: Dec 03, 2008
Creation Date: Dec 03, 2008
Archive Date: Mar 30, 2009
Total Program Funding: $3,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Tria...
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Tr...
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical T...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com